PDA001

BIOLOGICAL2 trials

Sponsors

Celularity Incorporated

Conditions

Crohns DiseaseRheumatoid Arthritis

Phase 1

A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease

CompletedNCT01769755

Celularity IncorporatedCrohns Disease

Start: 2013-03-31End: 2014-11-30Updated: 2018-03-01

Phase 2

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis

TerminatedNCT01261403

Celularity IncorporatedRheumatoid Arthritis

Start: 2010-12-31End: 2013-09-30Updated: 2020-07-22